Search research articles
Contact Us
Filters
Showing results (21-30 of 87) with videos related to
Page
of 9
Sort By:
BMC Medicine
|
July 4, 2026
Therapeutic activation of PPARα contributes to NOTCH1 inhibition in T-cell acute lymphoblastic leukemia
Wenjuan Li, Hui Zhou, Dongmei Qin, et al.
International Immunology
|
September 27, 2023
IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sjögren's syndrome
Xiaoyu Xia, Qiqiang Long, Jie Zha, et al.
Stem Cell Reviews and Reports
|
October 15, 2020
Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia
Jie Zha, Qian Lai, Manman Deng, et al.
International Immunopharmacology
|
July 7, 2023
The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease
Guochun Chen, Mengru Zeng, Zhiwen Liu, et al.
Blood Cells, Molecules & Diseases
|
May 24, 2014
Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome
Xutao Guo, Pengcheng Shi, Feili Chen, et al.
Biochemical Pharmacology
|
August 24, 2024
Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development
Huihui Chen, Jie Song, Li Zeng, et al.
Scientific Reports
|
August 12, 2025
Chidamide and anlotinib synergistically inhibit high grade B-cell lymphomas via PI3K/AKT signaling pathway
Jiazhen Lin, Xinguo Zhuang, Shuman Jia, et al.
Pharmacogenomics
|
July 27, 2017
Low-dose decitabine enhances chidamide-induced apoptosis in adult acute lymphoblast leukemia, especially for p16-deleted patients through DNA damage
Pengcheng Shi, Leisi Zhang, Kai Chen, et al.
Experimental Cell Research
|
November 28, 2017
CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma
Yong Zhou, Jie Zha, Zhijuan Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia
Hui Zhou, Dongmei Qin, Chendi Xie, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 87) with videos related to
Sort By:
Page
of 9
BMC Medicine
|
July 4, 2026
Therapeutic activation of PPARα contributes to NOTCH1 inhibition in T-cell acute lymphoblastic leukemia
Wenjuan Li, Hui Zhou, Dongmei Qin, et al.
International Immunology
|
September 27, 2023
IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sjögren's syndrome
Xiaoyu Xia, Qiqiang Long, Jie Zha, et al.
Stem Cell Reviews and Reports
|
October 15, 2020
Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia
Jie Zha, Qian Lai, Manman Deng, et al.
International Immunopharmacology
|
July 7, 2023
The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease
Guochun Chen, Mengru Zeng, Zhiwen Liu, et al.
Blood Cells, Molecules & Diseases
|
May 24, 2014
Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome
Xutao Guo, Pengcheng Shi, Feili Chen, et al.
Biochemical Pharmacology
|
August 24, 2024
Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development
Huihui Chen, Jie Song, Li Zeng, et al.
Scientific Reports
|
August 12, 2025
Chidamide and anlotinib synergistically inhibit high grade B-cell lymphomas via PI3K/AKT signaling pathway
Jiazhen Lin, Xinguo Zhuang, Shuman Jia, et al.
Pharmacogenomics
|
July 27, 2017
Low-dose decitabine enhances chidamide-induced apoptosis in adult acute lymphoblast leukemia, especially for p16-deleted patients through DNA damage
Pengcheng Shi, Leisi Zhang, Kai Chen, et al.
Experimental Cell Research
|
November 28, 2017
CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma
Yong Zhou, Jie Zha, Zhijuan Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia
Hui Zhou, Dongmei Qin, Chendi Xie, et al.
Page
of 9